comparemela.com

Latest Breaking News On - Angelica johansson - Page 1 : comparemela.com

IRLAB to Present Clinical and Preclinical Data at the AD/PD(TM) 2024: 18th International Conference on Alzheimer s & Parkinson s Diseases

27.02.2024 - GOTHENBURG, SWEDEN / ACCESSWIRE / February 27, 2024 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, February 27, 2024 - IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company discovering and developing novel treatments for .

Li rouskJenny gunnergrenJoakim tedroffAngelica johanssonDaniel anderssonGunnar olssonOlivia vu vanArvid carlssonSabina brandinDrug developmentResearch developmentMichaelj fox foundationPlacebo controlled phaseTrial evaluatingFalls frequencyClas sonesson

IRLAB to Present Clinical and Preclinical Data at the AD/PD(TM) 2024:

IRLAB to Present Clinical and Preclinical Data at the AD/PD(TM) 2024: .

Vastra gotalands lanGunnar olssonLi rouskSabina brandinJoakim tedroffArvid carlssonJenny gunnergrenOlivia vu vanAngelica johanssonDaniel anderssonMichaelj fox foundationInternational conference on alzheimerDrug developmentResearch developmentInternational conference on alzheimer parkinson diseasesNews network

IRLAB to Present Clinical and Preclinical Data at the AD/PD(TM) 2024: 18th International Conference

GOTHENBURG, SWEDEN / ACCESSWIRE / February 27, 2024 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, February 27, 2024 - IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company discovering and developing novel treatments for Parkinson's disease, today announced that the company will present two.

Vastra gotalands lanLi rouskGunnar olssonArvid carlssonAngelica johanssonJenny gunnergrenOlivia vu vanSabina brandinJoakim tedroffDaniel anderssonResearch developmentInternational conference on alzheimerDrug developmentMichaelj fox foundationNasdaq stockholmInternational conference

vimarsana © 2020. All Rights Reserved.